Abstract
The prevalence of antibodies to Epstein-Barr virus-determined antigens was studied in 17 children with acute infectious mononucleosis (IM) and in 263 children hospitalized for diseases unrelated to EBV infection. Antibodies against Epstein-Barr viral capsid antigens (VCA) were observed in 173 patients of the control group (66%), but 58 of them (33,5%) had not yet developed antibodies against Epstein-Barr virus-associated nuclear antigen (EBNA).
IgM-specific antibodies were not found in any of the children of the control group but were present in all of the 17 patients with IM. The rates of positivity for IgA anti-VCA and IgG anti-early antigen (EA) were similar in all age groups. Anti-viral capsid antigen IgG seropositivity increased to 83% by the age of six years, the mean geometric titre being highest between the ages of 2 and 4 years. Our results suggest that in Sicilian children the primary infection occurs prevalently early in life, in parallel with the occurrence of IM.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ammatuna P., Gerbasi F., Arista S. and Bellia L. (1983): Accertamenti sierodiagnostici in alcuni casi di sindrome mononucleosica infettiva. - BML 2: 81–87.
Ammatuna P., DeThè G., Speciale R., Sammartano F., Arista S. and Zerillo G. (1988): Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma. - Microbiologica 12: 89–94.
Desgranges C. and DeThè G. (1979): Epstein-Barr virus- specific IgA serum antibodies in nasopharyngeal and other respiratory carcinomas. -Int. J. Cancer 24: 555–559.
Dolken G., Bross K.J., Hecht T., Brugger W., LohrG.W. and Hisch F.W. (1986): Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocitic leukemia. - Int. J. Cancer 38: 55–59.
Epstein M.A. and Achong B.G. (1977): Recent progress in Epstein-Barr virus research. - Ann. Rev. Microbiol. 31: 421–445.
Hanto D., Frizzera G. and Putilo D.T. (1981): Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and incidence for the role of Epstein-Barr virus. - Cancer Res. 41: 4253–4261.
Henle G. and Henle W. (1966): Immunofluorescence in cells derived from Burkitt's. lymphoma. - J. Bacteriol. 91: 1248–1256.
Henle G. and Henle W. (1970): Observation on childhood infections with the Epstein-Barr virus. - J. Infect. Dis. 121: 303–310.
Henle G., Henle W. and Horwitz C.A. (1979): Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis. - In: M.A. Epstein and B.G. Achong (eds.). The Epstein-Barr virus, Springer, New York, pp. 297–320.
Henle W. and Henle G. (1973): Seroepidemiology of the Epstein-Barr virus. - In: M.A. Epstein and B.G. Achong (eds.) The Epstein-Barr virus, Springer, New York, pp. 62–78.
Henle W., Henle G. and Horwitz C.A. (1974): Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. - Hum. Pathol. 5: 551–565.
Jones J., Ray G., Minnich L.L., Hicks M.J., KiblerR. and Lucas D.O. (1985): Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. - Ann. Int. Med. 102: 1–6.
Kafuko G.W., Day N.E., Henderson B.E., Henle G., Henle W., Kirya G., Munube G., Morrow R.H., PieM.C., Smith P.G., Tukei P. and Williams E.M. (1972): Epstein-Barr virus antibody levels in children from the West Nile district of Uganda: Report of a field study. - Lancet 1: 706–709.
Karzon D.T. (1976): Infectious mononucleosis. - Adv. Pediatr. 22: 231–265.
Marklund G., Henle W., Henle G. and Ernberg I. (1986): IgA antibodies to Epstein-Barr virus in infectious mononucleosis. - Scand. J. Infect. Dis. 18: 111–118.
Nikoskelainen J., Leikola J. and Leikola E. (1974): IgM antibodies specific for Epstein-Barr virus infectious mononucleosis without heterophil antibodies. - Brit. Med. J. 4: 72–75.
Nikoskelainen J., Neel E.U. and Stevens D.A. (1979): Epstein-Barr virus-specific serum immunoglobulin A as an acute-phase antibody in infectious mononucleosis. - J. Clin. Microbiol. 10: 75–79.
Obererder H., Staube E., Kunkel M., Gaertener L. and Mortiadakis I. (1986): Epstein-Barr virus-specific immunoglobulin A in patients with infectious mononucleosis, an age-dependent factor. - Eur. J. Clin. Microbiol. 5: 173–174.
Reedman G.M. and Klein G. (1973): Cellular localization of an Epstein-Barr virus (EBV) associated complement-fixing antigen in producer and non producer lymphoblastoid cell lines. - Int. J. Cancer 11: 499–520.
Straus S., Tosato G., Armstrong G., Lawley T., PrebleO.T., Henle W., Davey R., Pearson G., Epstein J., BrusI. and Blease R.M. (1985): Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. - Ann. Int. Med. 102: 7–16.
Sugawara K., Mizuno F. and Osato T. (1972): Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines. - Nature New Biol. 239: 242–243.
Venkitaraman A.R., Lenoir G.M. and John T.J. (1985): The seroepidemiology of infection due to Epstein-Barr virus in Southern China. - J. Med. Virol. 15: 11–16.
Wang P.S. and Evans A. (1986): Prevalence of antibodies to Epstein-Barr virus and Cytomegalovirus in sera from a group of children in the People's Republic of China. - J. Infect. Dis. 153: 150–152.
Yadaw M.S., Malliga N. and Ablashi D.V. (1987): Development of Immunity to Epstein-Barr virus in Malaysian children. - Microbiologica 10: 29–35.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ammatuna, P., Di Stefano, R., Arista, S. et al. Immune status towards Epstein-Barr virus in a group of sicilian children. Eur J Epidemiol 5, 219–223 (1989). https://doi.org/10.1007/BF00156834
Issue Date:
DOI: https://doi.org/10.1007/BF00156834